Are healthcare economics a factor behind European MRSA rates?

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Michael A Borg

Abstract

This study assessed the relationship between meticillin-resistant Staphylococcus aureus (MRSA) prevalence in 26 European countries with two key socioeconomic parameters, namely, gross domestic product per capita (GDP) and infant mortality rate (IMR). Whilst no significant relationship was identified between MRSA and GDP (Spearman correlation: -0.387; 95% confidence interval [CI]: -0.674 to 0.000; p = 0.0528), a significant correlation was evident between MRSA and IMR (Spearman correlation: 0.545; 95% CI: 0.208 to 0.766; p = 0.005). The elimination of a widely outlying data point retained significance. Various studies have shown IMR to be a good marker of healthcare expenditure and it is, therefore, reasonable to postulate that one possible factor in the multi-factorial epidemiology of MRSA in Europe is the level and effectiveness of healthcare expenditure within the individual countries.

References

Jan 1, 1987·Social Science & Medicine·B Wolfe, M Gabay
Jan 10, 1985·The New England Journal of Medicine·M C McCormick
Oct 1, 1995·American Journal of Public Health·J ElolaV Navarro
Jan 1, 1994·International Journal of Technology Assessment in Health Care·A Babazono, A L Hillman
Nov 2, 1999·Health Economics·P Y CrémieuxC Pilon
Oct 23, 2004·Emerging Infectious Diseases·Edine W TiemersmaUNKNOWN European Antimicrobial Resistance Surveillance System Participants
Dec 7, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I M Gould

❮ Previous
Next ❯

Citations

Sep 10, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I M GouldA Walker
Dec 19, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Michael A Borg, Liberato Camilleri

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.